Description of Collaborative Activity: |
The Interagency Select Agent Review Group (ISARG), composed of members from the Food and Drug Administration (FDA), the Centers for Disease Control and Prevention (CDC), the Department of Justice, and the Department of State, advises the National Institute of Allergy and Infectious Diseases (NIAID) on whether facilities and procedures at NIAID-funded foreign research sites are comparable to those required by the Select Agent Regulations for domestic institutions before Select Agent work at the foreign site may proceed. |
Type of Collaborative Activity: |
Committee, Advisory Group, or Work Group
|